跳至主要内容
临床试验/NCT02385656
NCT02385656Unknown4 期

The Efficacy and Tolerability of Modafinil for Fatigue and Daytime Sleepiness in Cancer Patients: Preliminary Study

Seoul National University Bundang Hospital1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2013年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
20
试验地点
1
主要终点
severity of fatigue (Brief Fatigue Inventory)

研究概览

简要总结

Open-pilot study for the efficacy and tolerability of modafinil on the fatigue and somnolence in cancer-patients.

详细描述

This is an open-pilot study for the efficacy and tolerability of modafinil on the fatigue and somnolence in cancer-patients. Patients with moderate to severe cancer-related fatigue will be treated with modafinil for 4 weeks and psychological tests including self-questionnaire, cognitive test, sleep-wake cycle, quantitative electroencephalogram(QEEG) will be applied pre- and post-treatment.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • solid cancer patient
  • age of 20-65 years old
  • subjects who scored =4 or >4 on the Brief Fatigue Inventory
  • subjects with informed consent

排除标准

  • metastatic cancer(stage IV)
  • with psychotic symptoms such as delusion and hallucination or with suicidal risk
  • with delirium or dementia
  • current medication of cognitive enhancer or psychostimulant uncontrolled medical illness
  • current medications that are contraindicated or not recommended for co-administration with modafinil

研究组 & 干预措施

Intervention group

Experimental

Subjects who take modafinil for cancer-related fatigue for 4 weeks.

干预措施: Modafinil (Drug)

结局指标

主要结局

severity of fatigue (Brief Fatigue Inventory)

时间窗: 4 weeks

Brief Fatigue Inventory

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

In-Young Yoon

Professor

Seoul National University Bundang Hospital

研究点 (1)

Loading locations...

相似试验